W H Frist, E B Gerhardt, W H Merrill, J B Atkinson, T E Eastburn, J R Stewart, J W Hammon, H W Bender
{"title":"多疗程OKT3治疗难治性复发性心脏排斥反应。","authors":"W H Frist, E B Gerhardt, W H Merrill, J B Atkinson, T E Eastburn, J R Stewart, J W Hammon, H W Bender","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The treatment for recurrent cardiac allograft rejection refractory to conventional immunotherapy is retransplantation. When retransplantation is not possible, alternative approaches must be undertaken. This report reviews the successful management of persistently recurring rejection using five serial 14-day courses of OKT3 in a 35-year-old man after two heart transplantations.</p>","PeriodicalId":77638,"journal":{"name":"The Journal of heart transplantation","volume":"9 6","pages":"724-6"},"PeriodicalIF":0.0000,"publicationDate":"1990-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Therapy of refractory, recurrent heart rejection with multiple courses of OKT3.\",\"authors\":\"W H Frist, E B Gerhardt, W H Merrill, J B Atkinson, T E Eastburn, J R Stewart, J W Hammon, H W Bender\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The treatment for recurrent cardiac allograft rejection refractory to conventional immunotherapy is retransplantation. When retransplantation is not possible, alternative approaches must be undertaken. This report reviews the successful management of persistently recurring rejection using five serial 14-day courses of OKT3 in a 35-year-old man after two heart transplantations.</p>\",\"PeriodicalId\":77638,\"journal\":{\"name\":\"The Journal of heart transplantation\",\"volume\":\"9 6\",\"pages\":\"724-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of heart transplantation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of heart transplantation","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Therapy of refractory, recurrent heart rejection with multiple courses of OKT3.
The treatment for recurrent cardiac allograft rejection refractory to conventional immunotherapy is retransplantation. When retransplantation is not possible, alternative approaches must be undertaken. This report reviews the successful management of persistently recurring rejection using five serial 14-day courses of OKT3 in a 35-year-old man after two heart transplantations.